全球布局丨申基生物宣布与全球4家公司达成战略分销协议

此次协议的达成，标志着申基生物mRNA原料、小核酸药物原料、分子诊断原料等产品以及各类定制服务等全面进军美国、欧洲、中东、北非和韩国市场，加速该地区mRNA以及小核酸药物等的发展。

BIORON is a premium manufacturer and worldwide-acting distributor of molecular biological and diagnostic products with its head office in Germany since 2002. Our products fulfil highest quality and health standards and we are certified according to DIN EN ISO 13485:2016.

Medsol is a medical products & devices distributor established in 2014 with a head office in Egypt-Cairo and Main branch in Kingdom of Saudi Arabia-Riyadh, the company tradition business model is based on the delivery of medical innovative solutions for the served area, medical solution challenges to fulfill the market demands.

Areterna LLC was founded in 2023 as a wholly owned subsidiary of Synthgene Biotechnology Co., Ltd. to serve customers in the US and Europe. 

浙江易众化工有限公司成立于1998年，公司主营业务为医药中间体和原料药的进出口，形成了以韩国、日本、印度、欧洲市场为主，埃及、巴基斯坦和南美市场为辅的市场布局，并不断往其他市场渗透。

申基生物成立于2018年，专注于为客户提供生命科学领域上游原料的整体解决方案。公司核心成员源自南京大学化学生物学博士团队，拥有极强的化学生物学技术背景，多年来致力于生命科学卡脖子原料的研发和产业化，现已具有抗体发现平台、mRNA原液制备平台、mRNA-LNP制剂工艺平台、寡核苷酸制备平台、酶定向进化平台等技术，在此驱动下，衍生细胞基因治疗原料、基因核酸药物原料以及IVD原料三大产品板块。公司已入选南京市培育独角兽企业，已获多轮数亿元融资。